|
gptkb:beta-hCG
|
treatment response in cancer
|
|
gptkb:RPR
|
treatment response in syphilis
|
|
gptkb:Hepatitis_B_e_Antigen
|
response to antiviral therapy
|
|
gptkb:Humphrey_technique
|
optic nerve diseases
|
|
gptkb:Cluster_of_Differentiation_4
|
AIDS progression
|
|
gptkb:plasma_cholinesterase
|
exposure to nerve agents
|
|
gptkb:PASI
|
treatment response
|
|
gptkb:cytokeratin_19
|
treatment response
|
|
gptkb:cytokeratin_19
|
cancer progression
|
|
gptkb:chromogranin_A
|
gptkb:medullary_thyroid_carcinoma
|
|
gptkb:HBeAg
|
treatment response in chronic Hepatitis B
|
|
gptkb:chromogranin_A
|
gptkb:pheochromocytoma
|
|
gptkb:plasma_cholinesterase
|
exposure to pesticides
|
|
gptkb:chromogranin_A
|
paraganglioma
|
|
gptkb:chromogranin_A
|
gptkb:carcinoid_tumors
|
|
gptkb:CK18
|
cell death in clinical samples
|
|
gptkb:Hepatitis_B_e_antigen_(HBeAg)
|
antiviral therapy response
|